Hagström, H.; Nasr, P.; Ekstedt, M.; Hammar, U.; Widman, L.; Stål, P.; Hultcrantz, R.; Kechagias, S.; Henriksson, M. . (2019). Healthcare Costs of Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease are Nearly Twice Those of Matched Controls. Clinical Gastroenterology and Hepatology, (), S154235651931167X–.
doi:10.1016/j.cgh.2019.10.023
